Document is current
Any future updates will be listed below
-
Authors
Oulès, Bénédicte https://orcid.org/0000-0001-8269-4306
Mourah, Samia https://orcid.org/0000-0002-9283-1068
Baroudjian, Barouyr https://orcid.org/0000-0001-8234-6766
Jouenne, Fanélie https://orcid.org/0000-0002-6706-7424
Delyon, Julie https://orcid.org/0000-0002-4557-3377
Louveau, Baptiste https://orcid.org/0000-0001-5411-3893
Gruber, Aurélia
Lebbé, Céleste https://orcid.org/0000-0002-5854-7290
Battistella, Maxime https://orcid.org/0000-0002-7053-7431
- License Information
-
More Information
Article History
Received: 28 October 2020
Revised: 4 May 2021
Accepted: 9 May 2021
First Online: 20 May 2021
Declarations
: This study was performed after establishing the absence of registered opposition to the use of clinical and pathological data and tissue samples in accordance with French Bioethics Law for retrospective noninterventional research studies.
: The authors declare no conflict of interest regarding the publication of this article. B.O. declares grants to attend congresses from Novartis and BMS. A.G. and F.J. declare no conflict of interest. C.L. declares a consulting role for Amgen, BMS, MSD, Novartis, and Roche, research funding from BMS and Roche, honoraria from Amgen, BMS, Incyte, MSD, Novartis, Pfizer, Pierre Fabre and Roche, and travel accommodations from BMS. S.M. declares a consulting role for Novartis, Biocartis, and Roche and research funding from Biocartis. M.B. declares honoraria from Innate Pharma, Takeda, BMS, and Leo Pharma.
